Oxford Asset Management’s Emergent Biosolutions EBS Stock Holding History

Oxford Asset Management’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$478K	Buy	+57,638	New	+$597K	0.21%	158
2025 Q2	–	Sell	-64,377	Closed	-$313K	–	598
2025 Q1	$313K	Buy	+64,377	New	+$533K	0.14%	245
2024 Q4	–	Sell	-10,173	Closed	-$84.9K	–	496
2024 Q3	$84.9K	Buy	+10,173	New	+$92.5K	0.07%	280
2024 Q1	–	Sell	-27,754	Closed	-$66.6K	–	296
2023 Q4	$66.6K	Buy	+27,754	New	+$65.2K	0.1%	171
2019 Q1	–	Sell	-8,639	Closed	-$512K	–	1735
2018 Q4	$512K	Sell	8,639 -13,539	-61%	-$873K	0.01%	1191
2018 Q3	$1.46M	Sell	22,178 -3,738	-14%	-$218K	0.03%	834
2018 Q2	$1.32M	Buy	25,916 +10,351	+67%	+$539K	0.03%	893
2018 Q1	$819K	Sell	15,565 -27,954	-64%	-$1.39M	0.02%	1026
2017 Q4	$2.08M	Buy	43,519 +14,463	+50%	+$609K	0.04%	551
2017 Q3	$1.17M	Buy	29,056 +707	+2%	+$25.6K	0.02%	878
2017 Q2	$961K	Sell	28,349 -20,485	-42%	-$632K	0.02%	901
2017 Q1	$1.42M	Sell	48,834 -34,005	-41%	-$1.04M	0.04%	663
2016 Q4	$2.72M	Sell	82,839 -11,520	-12%	-$345K	0.1%	227
2016 Q3	$2.98M	Sell	94,359 -246,129	-72%	-$7.15M	0.09%	298
2016 Q2	$9.57M	Buy	340,488 +178,091	+110%	+$6.98M	0.32%	69
2016 Q1	$5.9M	Sell	162,397 -62,132	-28%	-$2.19M	0.17%	134
2015 Q4	$9M	Sell	224,529 -57,837	-20%	-$2.02M	0.21%	87
2015 Q3	$8.04M	Buy	282,366 +205,714	+268%	+$6.78M	0.25%	70
2015 Q2	$2.53M	Sell	76,652 -16,365	-18%	-$507K	0.07%	309
2015 Q1	$2.67M	Buy	93,017 +75,497	+431%	+$2.17M	0.07%	303
2014 Q4	$475K	Sell	17,520 -24,279	-58%	-$579K	0.01%	565
2014 Q3	$903K	Sell	41,799 -92,382	-69%	-$2.12M	0.02%	483
2014 Q2	$3.03M	Buy	134,181 +61,025	+83%	+$1.42M	0.1%	298
2014 Q1	$1.85M	Sell	73,156 -31,784	-30%	-$803K	0.05%	380
2013 Q4	$2.41M	Buy	104,940 +65,483	+166%	+$1.37M	0.06%	384
2013 Q3	$752K	Buy	39,457 +23,796	+152%	+$425K	0.02%	607
2013 Q2	$226K	Buy	+15,661	New	+$227K	0.01%	778